Life Tech Begins Clinical Trials of CE Sequencer for HLA Typing; Plans 510(k) Clearance
March 22, 2011
Life Tech Begins Clinical Trials of CE Sequencer for HLA Typing; Plans 510(k) Clearance
A clinical research organization will oversee the clinical trials at several independent, accredited HLA typing laboratories in the US. These labs will use the 3500 Dx Genetic Analyzer, SeCore kits, and uTYPE Dx software to analyze six gene regions of the HLA system.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Life Tech Submits 3500 CE Machine and HLA Typing Kit for FDA 510(k) Approval
August 3, 2011 / Clinical Sequencing News - Life Tech Sees Clinical Promise for NGS Panels, Exomes; Says Multiple Platforms to Drive Dx Strategy
August 1, 2012 / Clinical Sequencing News - People in the News
August 9, 2011 / Clinical Sequencing News - Illumina Sees Clinical Applications for MiSeq; Plans FDA Submission in 2012
August 3, 2011 / Clinical Sequencing News - IOM Workshop Discusses Interim Strategies to Handle Unresolved Challenges of Clinical Sequencing
July 27, 2011 / Clinical Sequencing News